𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MethCancerDB – aberrant DNA methylation in human cancer

✍ Scribed by Lauss, M; Visne, I; Weinhaeusel, A; Vierlinger, K; Noehammer, C; Kriegner, A

Book ID
109999406
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
65 KB
Volume
98
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aberrant methylation of Reprimo in human
Aberrant methylation of Reprimo in human malignancies
✍ Takao Takahashi; Makoto Suzuki; Hisayuki Shigematsu; Narayan Shivapurkar; Chinye 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 683 KB

## Abstract __Reprimo__ is a new candidate mediator of p53‐mediated cell cycle arrest at the G~2~ phase. Loss of __Reprimo__ gene expression accompanied by its promoter methylation was identified in pancreatic and lung cancers. Our aim was to examine the methylation status of __Reprimo__ in a broad

Aberrant DNA methylation occurs in colon
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model
✍ Scott C. Borinstein; Melissa Conerly; Slavomir Dzieciatkowski; Swati Biswas; M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Mouse models of intestinal tumors have advanced our understanding of the role of gene mutations in colorectal malignancy. However, the utility of these systems for studying the role of epigenetic alterations in intestinal neoplasms remains to be defined. Consequently, we assessed the role of aberran